Exosomes Derived From Mesenchymal Stem Cells Pretreated With Ischemic Rat Heart Extracts Promote Angiogenesis via the Delivery of DMBT1

Yi Xiao; Ye Zhang; Yuzhang Li; Nanyin Peng; Qin Liu; Danyang Qiu; Justin Cho; Cesario V Borlongan; Guolong Yu

doi:10.1177/09636897221102898

Exosomes Derived From Mesenchymal Stem Cells Pretreated With Ischemic Rat Heart Extracts Promote Angiogenesis via the Delivery of DMBT1

Cell Transplant. 2022 Jan-Dec:31:9636897221102898. doi: 10.1177/09636897221102898.

Authors

Yi Xiao¹, Ye Zhang¹, Yuzhang Li¹, Nanyin Peng¹, Qin Liu¹, Danyang Qiu¹, Justin Cho², Cesario V Borlongan², Guolong Yu¹

Affiliations

¹ Division of Cardiovascular, Xiangya Hospital, Central South University, Changsha, China.
² Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA.

Abstract

Mesenchymal stem cell-derived exosomes (MSC-Exos) have been shown to promote angiogenesis. Treating MSCs with ischemic rat brain extracts was sufficient to augment their benefits in stroke. However, no similar analyses of ischemic heart extracts have been performed to date. We aim to determine whether MSC-Exos derived from MSCs pretreated with ischemic rat heart extract were able to promote angiogenesis and to clarify underlying mechanisms. ELISA (enzyme-linked immunosorbent assay) of heart extracts revealed a significant increase of vascular endothelial growth factor (VEGF) at 24 h post-MI (myocardial infarction) modeling, and time-dependent decreases in hypoxia inducible factor-1α (HIF-1α). MTT and wound healing assays revealed human umbilical vein endothelial cells (HUVECs) migration and proliferation increased following MSC^E-Exo treatment (exosomes derived from MSC pretreated with ischemic heart extracts of 24 h post-MI) relative to MSC^N-Exo treatment (exosomes derived from MSC pretreated with normal heart extracts). Proteomic analyses of MSC^E-Exo and MSC^N-Exo were conducted to screen for cargo proteins promoting angiogenesis. Result revealed several angiogenesis-related proteins were upregulated in MSC^E-Exo, including DMBT1 (deleted in malignant brain tumors 1). When DMBT1 was silenced in MSCs, HUVECs with MSC^{DMBT1 RNAi}-Exo treatment exhibited impaired proliferative and migratory activity and reductions of DMBT1, p-Akt, β-catenin, and VEGF. To explore how ischemic heart extracts took effects, ELISA was conducted showing a significant increase of IL-22 at 24 h post-MI modeling. P-STAT3, IL22RA1, DMBT1, and VEGF proteins were increased in MSC^E relative to MSC^N, and VEGF and DMBT1 were increased in MSC^E-Exos. Together, these suggest that IL-22 upregulation in ischemic heart extracts can increase DMBT1 in MSCs. Exosomes derived from those MSCs deliver DMBT1 to HUVECs, thereby enhancing their migratory and proliferative activity.

Keywords: DMBT1; angiogenesis; exosome; ischemic rat heart extracts; mesenchymal stem cells.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Exosomes* / metabolism
Human Umbilical Vein Endothelial Cells
Humans
Mesenchymal Stem Cells* / metabolism
Myocardial Infarction* / metabolism
Myocardial Infarction* / therapy
Neovascularization, Pathologic
Neovascularization, Physiologic
Proteomics
Rats
Vascular Endothelial Growth Factor A / metabolism

Substances

Vascular Endothelial Growth Factor A